Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Paul Billings, Stephen Rusckowski

Premium

CollabRx has appointed Paul Billings to its board of directors. Billings most recently served as chief medical officer for Life Technologies. He is executive chairman of Melanoma Diagnostics, a director at Trovagene, and a co-founder and past medical director of the Cordblood Registry. He was also a senior VP for corporate development at Laboratory Corporation of America and a co-founder of Omicia.


Stephen Rusckowski has been named chairman of the American Clinical Laboratory Association's board of directors. Rusckowski has served as Quest Diagnostics' president and CEO since May 2012. Before joining Quest he was CEO of Philips Healthcare.

The Scan

Myotonic Dystrophy Repeat Detected in Family Genome Sequencing Analysis

While sequencing individuals from a multi-generation family, researchers identified a myotonic dystrophy type 2-related short tandem repeat in the European Journal of Human Genetics.

TB Resistance Insights Gleaned From Genome Sequence, Antimicrobial Response Assays

Researchers in PLOS Biology explore M. tuberculosis resistance with a combination of sequencing and assays looking at the minimum inhibitory concentrations of 13 drugs.

Mendelian Disease Genes Prioritized Using Tissue-Specific Expression Clues

Mendelian gene candidates could be flagged for further functional analyses based on tissue-specific transcriptome and proteome profiles, a new Journal of Human Genetics paper says.

Single-Cell Sequencing Points to Embryo Mosaicism

Mosaicism may affect preimplantation genetic tests for aneuploidy, a single-cell sequencing-based analysis of almost three dozen embryos in PLOS Genetics finds.